World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

Construction and Evaluation of Paclitaxel Mn-Doped Dendritic Mesoporous Silica Coated with N-Succinyl Chitosan

    https://doi.org/10.1142/S1793292024500516Cited by:0 (Source: Crossref)

    Mesoporous silica, as a drug carrier, has become the new research focus in the field of nanodrug delivery system in recent years. In this study, Mn-doped mesoporous silicas are synthesized by template and in-situ doping method and physically characterized. The drug-loading performance of silica and its impact on drug release are studied. The Mn-doped mesoporous silicas show dendritic morphology (MDMS) with a loose wrinkle structure on the surface and a large number of pores. MDMS is used as a carrier to solve the problem of low water solubility of paclitaxel. In order to avoid leakage during drug transportation, the surface of Mn-doped mesoporous silica loaded with paclitaxel is coated with N-succinyl chitosan to construct a new type of nanodrug delivery system (MDMS-PTX-NSC). Compared to MDMS, MDMS-PTX-NSC shows an increase in particle size and smooth surface. The dissolution characteristics of manganese ions and swelling behavior of N-succinyl chitosan make MDMS-PTX-NSC delivery system exhibit a good pH-responsive release. And MDMS-PTX-NSC release curve can be well fitted by Ritger-Peppas equation. The cytotoxicity test shows that the MDMS-PTX-NSC has significant biocompatibility and enhanced cytotoxicity, which reveals that the MDMS-PTX-NSC is a promising nanodrug delivery system.